Aristotle Capital Boston, LLC Avid Bioservices, Inc. Transaction History

Aristotle Capital Boston, LLC

$2.93 Billion
Q3 2024

A detailed history of Aristotle Capital Boston, LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Aristotle Capital Boston, LLC holds 766,340 shares of CDMO stock, worth $9.3 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

766,340

Previous 714,187 7.3%

Holding current value

$9.3 Million

Previous $5.1 Million 71.01%

% of portfolio

0.3%

Previous 0.18%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.7 - $12.45 $349,425 - $649,304	52,153 Added 7.3%	766,340 $8.72 Million
Q2 2024 Aug 14, 2024	SELL	$6.34 - $9.28 $97,591 - $142,847	-15,393 Reduced 2.11%	714,187 $5.1 Million
Q1 2024 May 15, 2024	SELL	$5.86 - $8.79 $41,963 - $62,945	-7,161 Reduced 0.97%	729,580 $4.89 Million
Q4 2023 Feb 14, 2024	BUY	$4.64 - $9.56 $287,489 - $592,328	61,959 Added 9.18%	736,741 $4.79 Million
Q3 2023 Nov 14, 2023	BUY	$9.4 - $14.04 $129,691 - $193,709	13,797 Added 2.09%	674,782 $6.37 Million
Q2 2023 Aug 14, 2023	SELL	$12.96 - $20.93 $80,066 - $129,305	-6,178 Reduced 0.93%	660,985 $9.23 Million
Q1 2023 May 15, 2023	BUY	$13.48 - $18.79 $118,327 - $164,938	8,778 Added 1.33%	667,163 $12.5 Million
Q4 2022 Feb 14, 2023	SELL	$12.61 - $18.74 $175,594 - $260,954	-13,925 Reduced 2.07%	658,385 $9.07 Million
Q3 2022 Nov 14, 2022	SELL	$15.33 - $20.36 $603,879 - $802,021	-39,392 Reduced 5.53%	672,310 $12.9 Million
Q2 2022 Aug 15, 2022	BUY	$11.63 - $21.55 $2.54 Million - $4.71 Million	218,674 Added 44.35%	711,702 $10.9 Million
Q1 2022 May 16, 2022	BUY	$16.63 - $27.73 $586,490 - $977,953	35,267 Added 7.7%	493,028 $10 Million
Q4 2021 Feb 14, 2022	SELL	$20.7 - $34.18 $7,307 - $12,065	-353 Reduced 0.08%	457,761 $13.4 Million
Q3 2021 Nov 15, 2021	SELL	$19.05 - $28.32 $56,254 - $83,628	-2,953 Reduced 0.64%	458,114 $9.88 Million
Q2 2021 Aug 16, 2021	SELL	$18.93 - $25.65 $329,457 - $446,412	-17,404 Reduced 3.64%	461,067 $11.8 Million
Q1 2021 May 17, 2021	BUY	$11.86 - $21.77 $61,316 - $112,550	5,170 Added 1.09%	478,471 $8.72 Million
Q4 2020 Feb 16, 2021	BUY	$7.25 - $11.76 $2.6 Million - $4.22 Million	358,425 Added 312.01%	473,301 $5.46 Million
Q3 2020 Nov 16, 2020	BUY	$6.53 - $8.6 $750,140 - $987,933	114,876 New	114,876 $875,000

Others Institutions Holding CDMO

# of Institutions

184

Shares Held

67.8M

Call Options Held

89.9K

Put Options Held

118K

View Full List

About Avid Bioservices, Inc.

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $755M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

More about CDMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Boston, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Boston, LLC with notifications on news.

Account

Aristotle Capital Boston, LLC Avid Bioservices, Inc. Transaction History